Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is employed by Penn Medicine.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014 - 2018

Recognized by Best Doctors in America - 2013 - 2018

Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • ObGyn/GynecologicOncology (AMA)
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Hysterectomy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center

Memberships

American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists, National American College of Surgeons (FACS), fellow, National GOG Foundation, National Gynecologic Oncology Group, National National Cancer Institute (NCI), Investigator, National NRG Oncology, International NRG Oncology, National Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Society of Gynecologic Oncology (SGO), National Tina's Wish Foundation, National

Hospital Affiliation

Dr. Burger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Eskander RN, Kauderer J, Tewari KT, Mannel RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan J-M, Burger RA: Correlation between surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study Gynecol Oncol In Press : 2018.

Mastroyannis SA, Johnson D, Gutman S, Morgan MA, Burger RA, Giuntoli RL II, Latif NA, Ko EM, Haggerty AF.: How much is enough? Narcotic prescribing practices and patient-reported outcomes from a single institution quality improvement project. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) : 2018.

Graul A, Haggerty AF, Brensinger CM, Lin LL, Giuntoli RL II, Latif NA, Kim SH, Burger RA, Morgan MA, Ko EM.: Variation in adjuvant therapy for stage II serous uterine cancer in the United States and its impact on survival. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) : 2018.

Gockley AA, Cronin A, Bookman MA, Burger RA, Cristea M, Griggs JJ, Mantia-Smaldone GM, Meyer LA, O'Malley DM, Wright AA.: Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) : 2018.

Cory L, Brensinger CM, Haggerty AF, Giuntoli RL II, Latif NA, Burger RA, Morgan MA, Lin LL, Ko EM.: Differences in overall survival associated with type and sequence of adjuvant therapy in stage I uterine carcinosarcoma. Poster presented at the SGO Annual Meeting on Women's Cancer, New Orleans LA. (Abstract) : 2018.

Roy AG, Brensinger CM, Lin LL, Giuntoli RL II, Haggerty AF, Latif NA, Burger RA, Morgan MA, Ko EM.: Endometrial cancer survival outcomes differ by geographical region. Poster presentation at the SGO Annual Meeting on Women's Cancer, New Orleans LA (Abstract) : 2018.

Bais C, Mueller B, Brady MF, Mannel RS, Burger RA, Wei W, Marien KM, Kockx MM, Husain A, Birrer MJ: Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses. J Natl Cancer Inst 109 (11): 2017.

Shalowitz DI, Nivasch E, Burger RA, Schapira MM: Are Patients Willing to Travel for Better Ovarian Cancer Care? Gynecol Oncol In Press : 2017.

Phippen NT, Secord AA, Wolf S, Samsa G, Davidson B, Abernethy AP, Cella D, Havrilevsky LJ, Burger RA, Monk BJ: Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: an ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study Gynecol Oncol 147 (1): 2017.

Oliver KE, Brady WE, Birrer MJ, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Alvarez-Secord A, Stephan J-M, Mutch DG, Stehman FB, Muggia FM, Rose PG, Armstrong DK, Bookman MA, Burger RA.: An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience. Gynecol Oncol In Press : 2017.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
Smilow CTR 8-104

Philadelphia, PA 19104-5156
Phone: (215) 746-4043
Patient appointments: 800-789-7366 (PENN)